Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | HALO | NUVL | ||
| Company | Cytokinetics | Halozyme Therapeutic | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 51.61 | 55.65 | 89.00 | ||
| High | 52.37 | 57.62 | 91.31 | ||
| Low | 51.02 | 52.56 | 87.25 | ||
| Last | 51.82 | 57.15 | 89.22 | ||
| Change | +0.82 | +6.58 | +0.73 | ||
| % Change | +1.61% | +13.01% | +0.82% | ||
| Volume | 881,800 | 3,404,000 | 755,700 | ||
| 20-Day Average Volume | 908,760 | 1,428,025 | 444,990 | ||
| Previous Close | 51.00 | 50.57 | 88.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 53.51 | 52.10 | 98.13 | ||
| 20-Day Raw Stochastic | 19.98% | 90.92% | 10.33% | ||
| 20-Day Relative Strength | 44.02% | 56.38% | 42.39% | ||
| Weighted Alpha | -16.91 | +58.32 | +41.90 | ||
| Today's Opinion | 100% Sell | 64% Buy | 56% Buy | ||
| Previous Opinion | 100% Sell | 8% Sell | 56% Buy | ||
| Last Month's Opinion | 40% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.97% since 10/25/24 | +16.04% since 10/25/24 | -1.63% since 10/25/24 | ||
| Low | 50.53 on 10/31/24 | 49.71 on 10/28/24 | 87.25 on 11/01/24 | ||
| High | 53.32 on 10/28/24 | 57.62 on 11/01/24 | 93.47 on 10/28/24 | ||
| 1-Month | |||||
| %Chg | -1.48% since 10/01/24 | +0.90% since 10/01/24 | -13.40% since 10/01/24 | ||
| Low | 50.53 on 10/31/24 | 48.84 on 10/25/24 | 87.25 on 11/01/24 | ||
| High | 56.99 on 10/07/24 | 62.00 on 10/03/24 | 106.32 on 10/14/24 | ||
| 3-Month | |||||
| %Chg | -10.52% since 08/01/24 | +3.81% since 08/01/24 | +17.06% since 08/01/24 | ||
| Low | 50.53 on 10/31/24 | 48.84 on 10/25/24 | 64.67 on 08/08/24 | ||
| High | 58.68 on 08/29/24 | 65.53 on 08/29/24 | 113.51 on 09/16/24 | ||
| 6-Month | |||||
| %Chg | -18.23% since 05/01/24 | +45.42% since 05/01/24 | +26.28% since 05/01/24 | ||
| Low | 46.25 on 05/28/24 | 38.88 on 05/02/24 | 64.18 on 05/10/24 | ||
| High | 68.44 on 05/09/24 | 65.53 on 08/29/24 | 113.51 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,097,141 | 7,239,648 | 5,781,277 | ||
| Shares Outstanding, K | 117,660 | 126,678 | 64,798 | ||
| Annual Sales | 7,530,000 | 829,250,000 | 0 | ||
| Annual Net Income | -526,240,000 | 281,590,000 | -126,220,000 | ||
| Last Quarter Sales | 250,000 | 231,350,000 | 0 | ||
| Last Quarter Net Income | -143,320,000 | 93,250,000 | -57,170,000 | ||
| 60-Month Beta | 0.78 | 1.29 | 1.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.31 on 08/08/24 | 1.27 on 10/31/24 | -0.88 on 08/08/24 | ||
| Latest Earnings Date | 11/06/24 | 10/31/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.53 | 0.00 | ||